Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HAGAN RM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Starkey, SJ; Grant, AL; Hagan, RM
      A rapid transient synthesis of nitric oxide (NO) by a constitutively expressed type IINO synthase in the guinea-pig suprachiasmatic nucleus

      BRITISH JOURNAL OF PHARMACOLOGY
    2. Patten, C; Clayton, CL; Blakemore, SJ; Trower, MK; Wallace, DM; Hagan, RM
      Identification of two novel diurnal genes by screening of a rat brain cDNAlibrary

      NEUROREPORT
    3. Drijfhout, WJ; de Vries, JB; Homan, EJ; Brons, HF; Copinga, S; Gruppen, G; Beresford, IJM; Hagan, RM; Grol, CJ; Westerink, BHC
      Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitude

      EUROPEAN JOURNAL OF PHARMACOLOGY
    4. Patten, C; Clayton, CL; Blakemore, SJ; Trower, MK; Wallace, DM; Hagan, RM
      Identification of two novel diurnal genes by screening of a rat brain cDNAlibrary

      NEUROREPORT
    5. STARKEY SJ; HAGAN RM; XIE XM
      A TRANSIENT NITRIC-OXIDE (NO) SIGNAL IS ATTENUATED BY A TYPE-II NO SYNTHASE INHIBITOR IN THE SUPRACHIASMATIC NUCLEUS OF THE GUINEA-PIG IN-VITRO

      European journal of neuroscience
    6. XIE XM; HAGAN RM
      CELLULAR AND MOLECULAR ACTIONS OF LAMOTRIGINE - POSSIBLE MECHANISMS OF EFFICACY IN BIPOLAR DISORDER

      Neuropsychobiology
    7. BERESFORD IJM; BROWNING C; STARKEY SJ; BROWN J; FOORD SM; COUGHLAN J; NORTH PC; DUBOCOVICH ML; HAGAN RM
      GR196429 - A NONINDOLIC AGONIST AT HIGH-AFFINITY MELATONIN RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    8. SOUTHAM E; KIRKBY D; HIGGINS GA; HAGAN RM
      LAMOTRIGINE INHIBITS MONOAMINE UPTAKE IN-VITRO AND MODULATES 5-HYDROXYTRYPTAMINE UPTAKE IN RATS

      European journal of pharmacology
    9. DRIJFHOUT WJ; BRONS HF; OAKLEY N; HAGAN RM; WESTERINK BHC
      A MICRODIALYSIS STUDY ON PINEAL MELATONIN RHYTHMS IN RATS AFTER AN 8-H PHASE ADVANCE - NEW CHARACTERISTICS OF THE UNDERLYING PACEMAKER

      Neuroscience
    10. CARLEY DW; HAGAN RM; SHEEHAN M; TRBOVIC S; THAI T; RADULOVACKI M
      ADENOSINE AL RECEPTOR AGONIST GR79236 SUPPRESSES APNEA DURING ALL SLEEP STAGES IN THE RAT

      Sleep
    11. MARSHALL FH; STRATTON SC; MULLINGS J; FORD E; WORTON SP; OAKLEY NR; HAGAN RM
      DEVELOPMENT OF TOLERANCE IN MICE TO THE SEDATIVE EFFECTS OF THE NEUROACTIVE STEROID MINAXOLONE FOLLOWING CHRONIC EXPOSURE

      Pharmacology, biochemistry and behavior
    12. BERESFORD IJM; STARKEY SJ; OAKLEY NR; STRATTON SC; HAGAN RM
      GR196429, A NON-INDOLIC AGONIST AT HIGH-AFFINITY MELATONIN RECEPTORS WHICH MEDIATE THE ACTIONS OF MELATONIN ON THE RAT CIRCADIAN CLOCK

      British Journal of Pharmacology
    13. STRATTON SC; BERESFORD IJM; HAGAN RM
      AUTORADIOGRAPHIC LOCALIZATION OF TACHYKININ NK2 RECEPTORS IN ADULT-RAT BRAIN USING [H-3] SR47968

      British Journal of Pharmacology
    14. STRATTON SC; BERESFORD IJM; HAGAN RM; MARSDEN CA
      GR159897, A NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONIST, DECREASES 5-HYDROXYTRYPTAMINERGIC CELL FIRING IN THE DORSAL RAPHE NUCLEUS OF THERAT

      British Journal of Pharmacology
    15. STARKEY SJ; WALKER MP; BERESFORD IJM; HAGAN RM
      MODULATION OF THE RAT SUPRACHIASMATIC CIRCADIAN CLOCK BY MELATONIN IN-VITRO

      NeuroReport
    16. KILPATRICK GJ; HAGAN RM; GALE JD
      5-HT3 AND 5-HT4 RECEPTORS IN TERMINAL REGIONS OF THE MESOLIMBIC SYSTEM

      Behavioural brain research
    17. HAWCOCK AB; BERESFORD IJM; MARSHALL FH; HAGAN RM
      TEMPERATURE AND AGONIST DEPENDENCY OF TACHYKININ NK1 RECEPTOR ANTAGONIST POTENCIES IN RAT ISOLATED SUPERIOR CERVICAL-GANGLION

      European journal of pharmacology
    18. GUO JZ; YOSHIOKA K; ZHAO FY; HOSOKI R; MAEHARA T; YANAGISAWA M; HAGAN RM; OTSUKA M
      PHARMACOLOGICAL CHARACTERIZATION OF GR82334, A TACHYKININ NK1 RECEPTOR ANTAGONIST, IN THE ISOLATED SPINAL-CORD OF THE NEONATAL RAT

      European journal of pharmacology
    19. BERESFORD IJM; SHELDRICK RLG; BALL DI; TURPIN MP; WALSH DM; HAWCOCK AB; COLEMAN RA; HAGAN RM; TYERS MB
      GR159897, A POTENT NONPEPTIDE ANTAGONIST AT TACHYKININ NK2 RECEPTORS

      European journal of pharmacology
    20. BEATTIE DT; CONNOR HE; HAGAN RM
      RECENT DEVELOPMENTS IN TACHYKININ NK1 RECEPTOR ANTAGONISTS - PROSPECTS FOR THE TREATMENT OF MIGRAINE HEADACHE

      Canadian journal of physiology and pharmacology
    21. BEATTIE DT; BERESFORD IJM; CONNOR HE; MARSHALL FH; HAWCOCK AB; HAGAN RM; BOWERS J; BIRCH PJ; WARD P
      THE PHARMACOLOGY OF GR203040, A NOVEL, POTENT AND SELECTIVE NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONIST

      British Journal of Pharmacology
    22. MAUBACH KA; HAGAN RM; JONES RSG
      ELECTROPHYSIOLOGICAL CHARACTERIZATION OF TACHYKININ RECEPTORS IN THE RAT NUCLEUS-TRACTUS-SOLITARIUS IN-VITRO - NEUROKININ-A MAY ACT AT ANNK1 RECEPTOR SUBTYPE

      British Journal of Pharmacology
    23. HAGAN RM; OAKLEY NR
      MELATONIN COMES OF AGE

      Trends in pharmacological sciences
    24. WALSH DM; STRATTON SC; HARVEY FJ; BERESFORD IJM; HAGAN RM
      THE ANXIOLYTIC-LIKE ACTIVITY OF GR159897, A NON PEPTIDE NK2 RECEPTOR ANTAGONIST, IN RODENT AND PRIMATE MODELS OF ANXIETY

      Psychopharmacology
    25. STABLES JM; BERESFORD IJM; ARKINSTALL S; IRELAND SJ; WALSH DM; SEALE PW; WARD P; HAGAN RM
      GR138676, A NOVEL PEPTIDIC TACHYKININ ANTAGONIST WHICH IS POTENT AT NK3 RECEPTORS

      Neuropeptides
    26. BALL DI; BERESFORD IJM; WREN GPA; PENDRY YD; SHELDRICK RLG; WALSH DM; TURPIN MP; HAGAN RM; COLEMAN RA
      IN-VITRO AND IN-VIVO PHARMACOLOGY OF THE NONPEPTIDE ANTAGONIST AT TACHYKININ NK(2) RECEPTORS, GR159897

      British Journal of Pharmacology
    27. STRATTON SC; BERESFORD IJM; HAGAN RM
      GR159897, A POTENT NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONIST, RELEASES SUPPRESSED BEHAVIORS IN A NOVEL AVERSIVE ENVIRONMENT

      British Journal of Pharmacology
    28. WALSH DM; BERESFORD IJM; HAGAN RM
      PROFILE OF GR159897, A NONPEPTIDE TACHYKININ NK2 RECEPTOR ANTAGONIST,IN A PRIMATE INTRUDER RESPONSE MODEL

      British Journal of Pharmacology
    29. MARSHALL FH; SMITH GD; TURPIN MP; FALLAIZE LA; BERESFORD IJM; BIRCH PJ; HAGAN RM
      MEASUREMENT OF THE CNS PENETRATION OF TACHYKININ NK1 RECEPTOR ANTAGONISTS IN THE GERBIL USING EX-VIVO BINDING AND A SCRATCHING RESPONSE

      British Journal of Pharmacology
    30. SMITH PW; MCELROY AB; PRITCHARD JM; DEAL MJ; EWAN GB; HAGAN RM; IRELAND SJ; BALL D; BERESFORD I; SHELDRICK R; JORDAN CC; WARD P
      LOW-MOLECULAR-WEIGHT NEUROKININ-NK(2) ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    31. KARAGIANNIS K; STAVROPOULOS G; POULOS C; JORDAN CC; HAGAN RM
      SYNTHESIS OF A POTENT ANTAGONIST OF SUBSTANCE-P BY REPLACING THE CH2SCH3 AND THE ALPHA-CARBOXAMIDE GROUPS OF THE METHIONINE AT [ORN6]-SP(6-11) BY BENZYL ESTER GROUPS

      International journal of peptide & protein research
    32. HAGAN RM; BERESFORD IJM; STABLES J; DUPERE J; STUBBS CM; ELLIOT PJ; SHELDRICK RLG; CHOLLET A; KAWASHIMA E; MCELROY AB; WARD P
      CHARACTERIZATION, CNS DISTRIBUTION AND FUNCTION OF NK2 RECEPTORS STUDIED USING POTENT NK2 RECEPTOR ANTAGONISTS

      Regulatory peptides
    33. GUO JZ; YOSHIOKA K; YANAGISAWA M; HAGAN RM; OTSUKA M
      BLOCKADE OF CUTANEOUS NERVE-EVOKED RESPONSES BY GR71251 IN THE ISOLATED SPINAL-CORD PREPARATION OF NEWBORN RAT

      Regulatory peptides
    34. PALEA S; DALFORNO G; GAVIRAGHI G; HAGAN RM; TRIST DG; PIETRA C
      FURTHER-STUDIES ON THE EFFECTS OF SELECTIVE NEUROKININ AGONISTS UPON THE ACTIVATION OF MICTURITION REFLEX IN RATS - EVIDENCE FOR A DUAL NK-1 RECEPTOR-MEDIATED EXCITATORY AND INHIBITORY ACTIVITY

      Neuropeptides
    35. STRATTON SC; BERESFORD IJM; HARVEY FJ; TURPIN MP; HAGAN RM; TYERS MB
      ANXIOLYTIC ACTIVITY OF TACHYKININ NK2, RECEPTOR ANTAGONISTS IN THE MOUSE LIGHT-DARK BOX

      European journal of pharmacology
    36. SUZUKI H; YOSHIOKA K; MAEHARA T; HAGAN RM; NAKANISHI S; OTSUKA M
      PHARMACOLOGICAL CHARACTERISTICS OF TACHYKININ RECEPTORS MEDIATING ACETYLCHOLINE-RELEASE FROM NEONATAL RAT SPINAL-CORD

      European journal of pharmacology
    37. GUO JZ; YOSHIOKA K; YANAGISAWA M; HOSOKI R; HAGAN RM; OTSUKA M
      DEPRESSION OF PRIMARY AFFERENT-EVOKED RESPONSES BY GR71251 IN THE ISOLATED SPINAL-CORD OF THE NEONATAL RAT

      British Journal of Pharmacology
    38. HAGAN RM; MCLEAN S
      VINEYARD PEPTIDE CONFERENCE BEARS FRUIT

      Trends in pharmacological sciences
    39. HAGAN RM; KILPATRICK GJ; TYERS MB
      INTERACTIONS BETWEEN 5-HT(3) RECEPTORS AND CEREBRAL DOPAMINE FUNCTION- IMPLICATIONS FOR THE TREATMENT OF SCHIZOPHRENIA AND PSYCHOACTIVE SUBSTANCE-ABUSE

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 16:54:42